NIH Grant Success Rate Falls to 17%, Lowest in Nearly Three Decades
March 15, 2026 · 2 min read
Claire Cummings
Despite distributing $36.58 billion in total awards during FY2025, the National Institutes of Health saw its grant success rate plummet to approximately 17% — the lowest level in nearly 30 years and a steep drop from 26% the prior year, according to the 2026 update of United for Medical Research's annual economic impact analysis released March 10.
5,564 Fewer Grants Despite Record Spending
The paradox is striking: NIH distributed more money than ever, yet awarded 5,564 fewer individual grants compared to FY2024. Nineteen states plus the District of Columbia experienced at least a 10% decline in award numbers.
The driver is a significant shift toward multi-year funding obligations. Approximately 7% of total grant funding used this mechanism in FY2025, up from 5% the prior year. The move — driven partly by NIH's need to meet its September 30 fiscal deadline following earlier administrative delays — concentrates dollars into fewer, larger commitments at the expense of new awards.
The $94 Billion Economic Engine
The report's economic case for NIH funding remains powerful. Federal research dollars generated $94.15 billion in new economic activity and supported 390,863 jobs nationwide in FY2025 — a return of $2.57 for every dollar invested. Over the past decade, NIH has generated over $822 billion in cumulative economic activity and supported more than 3.7 million positions.
Early-Career Researchers Face a Narrowing Path
The drop in success rates hits early-career investigators hardest. With fewer awards available, first-time R01 applicants face an increasingly narrow path to funding. Established labs with multi-year mechanisms are better insulated, but the broader research pipeline risks long-term damage if new investigators cannot secure initial awards.
For researchers navigating this tighter funding environment, diversifying beyond NIH is increasingly critical. Tools like Granted can help identify alternative funding sources — from SBIR mechanisms to foundation grants — that reduce dependence on the increasingly competitive NIH pool.